Join us for the 15th Annual Run for Their Lives 5K happening in-person on September 21, 2024! Your participation will help raise awareness of bleeding disorders and help raise needed funds for education and advocacy. Run through beautiful tree…
Join us on Saturday, September 21, 2024, at the North Park Swimming Pool for the 16th Annual Unite for Bleeding Disorders Walk! The Unite for Bleeding Disorders Walk brings our community together. It unites families with bleeding disorders and…
Women and teens with hemophilia or rare factor deficiencies from across the country are invited to apply for the Hemophilia Foundation of Michigan’s seventh annual National Conference for Women and Teens with Hemophilia and Rare Factor Deficiencies…
A new review published in the European Journal of Haematology describes the challenges inherent in managing both bleeding and excessive clot risk in patients with primary immune thrombocytopenia (ITP). Primary ITP is a rare…
The Women’s Retreat is a weekend-long educational retreat open to women who are affected by bleeding disorders as patients, spouses, or caregivers. This year, we are taking our women on a road trip to the Gulf! We have secured two beach…
Pathway to Cures (P2C) is the National Bleeding Disorders Foundation’s venture philanthropy fund created specifically to accelerate the development of cures and therapies across all inheritable blood and bleeding disorders.As a flexible partner…
Data provided by the National Bleeding Disorders Foundation (NBDF) was referenced recently in the coverage of a tragic case in Chelsea that took a dark turn for 3-year-old Yael Guardado Prudencio, a child with hemophilia and a seizure disorder. This…
On April 2, 2024, 8 News Now covered our Las Vegas Chapter's Winter Wine Walk with Stephanie Dupree. Stephanie Dupree, NBDF Development Manager of the NV Chapter, said, "This is our 9th annual Winter wine fest started by a bunch of wine lovers, and…
New York, NY, April 18, 2024 – Pathway to Cures (P2C) announced its collaborative partnership with Afimmune to support the development of Epeleuton as a potential therapeutic for Sickle Cell Disease (SCD).Pathway to Cures is the…